Why read?
This is a comprehensive article of the role of genome mapping in orthopedic medicine, posing the question why more healthcare providers are not using this information, and finally highlighting 8 startups that are leveraging genome mapping in their business models.
In orthopedics over the last decade, we've seen incredible advances—from robotic-assisted surgeries to 3D-printed implants. But here's a question that's been buzzing in my mind: With whole genome sequencing now dipping toward $100 per genome, why aren't we mapping the DNA of every patient walking into our clinics?
Imagine tailoring treatments for cartilage repair, tendon healing, or even optimizing bone ingrowth around a titanium implant based on a patient's unique genetic blueprint. It sounds like science fiction, but the tech is here. So, what's holding us back? Let's dive deep into the science, the promise, and the practical hurdles.
The Dramatic Drop in Genome Sequencing Costs
Remember when sequencing the first human genome cost billions and took years? Fast-forward to 2025: Costs have plummeted faster than Moore's Law predicted. As of 2024, industry leader Illumina offers whole genome sequencing for aro...
